Physician profile
Michael R Weber
NPI 1295992535
$31,195.01
in general payments reported to CMS, 2019-2025
51 companies · $17K in 2025
The $17K reported for 2025 was more than what 87% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,553 · 2020: $6,769 · 2021: $610 · 2022: $1,665 · 2023: $1,727 · 2024: $981 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $15K · Food and Beverage: $3,656 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $903 · Consulting Fee: $39.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $15,000.25 |
| Food and Beverage | $3,656.40 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $902.50 |
| Consulting Fee | $39.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $15,943.63 | 2025 | Amvuttra |
| Glenmark Pharmaceuticals Limited | $6,000.00 | 2020 | |
| Medtronic Vascular, INC. | $1,980.91 | 2019-2020 | |
| Medtronic, INC. | $1,223.54 | 2021-2025 | Micra, Selectsecure, Selectsite |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $703.12 | 2019-2024 | Lifevest |
| Janssen Pharmaceuticals, INC | $669.47 | 2019-2024 | Xarelto |
| Abbott Laboratories | $527.23 | 2019-2025 | Gallant, Jot Dx, Aveir |
| E.R. Squibb & Sons, L.L.C. | $387.46 | 2019-2025 | Eliquis, Camzyos |
| Biotronik INC. | $378.00 | 2019-2025 | Acticor 7 Vr-T Dx |
| Pfizer INC. | $332.30 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $327.59 | 2019-2024 | |
| Biosense Webster, INC. | $284.90 | 2021-2025 | Carto 3 |
| Kestra Medical Technology Services, INC. | $246.01 | 2022-2023 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $188.48 | 2020-2025 | Jardiance |
| Philips North America LLC | $173.22 | 2020-2025 | (5091) Amb Mon & Diag Und, Ambulatory Monitoring & Diagnostics Undivided |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braemar Manufacturing, LLC | $162.73 | 2019 | |
| Briohealth Solutions, INC. | $148.49 | 2025 | Briovad |
| Atricure, INC. | $141.59 | 2022 | |
| Bardy Diagnostics, INC. | $91.56 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $86.03 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $84.63 | 2023-2025 | Gardasil 9, Capvaxive, Verquvo |
| Boston Scientific Corporation | $78.30 | 2020-2025 | Lux-Dx Insertable Cardiac Monitor |
| Exact Sciences Corporation | $70.97 | 2023-2024 | Cologuard Collection Kit |
| Janssen Scientific Affairs, LLC | $69.44 | 2022 | |
| Corium, LLC | $68.40 | 2024-2025 | Azstarys |
| Baxter Healthcare | $58.63 | 2023 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Astrazeneca Pharmaceuticals LP | $53.15 | 2019-2022 | |
| Daiichi Sankyo INC. | $51.17 | 2024 | Injectafer |
| Insulet Corporation | $42.92 | 2022-2023 | Omnipod |
| Cvrx, INC. | $41.84 | 2024 | Barostim Neo System |
| Neurelis, INC. | $41.55 | 2024 | Valtoco |
| Amryt Pharma Holdings LTD | $41.49 | 2022-2023 | Mycapssa |
| Amneal Pharmaceuticals LLC | $40.67 | 2022-2024 | Unithroid |
| Davol INC. | $40.62 | 2025 | Arista |
| Medicomp INC | $37.00 | 2023 | Telepatch Cardiac Monitor |
| Amgen INC. | $36.79 | 2019-2023 | Evenity |
| Impulse Dynamics (USA) INC. | $35.52 | 2021 | |
| Chiesi USA, INC. | $34.64 | 2022-2024 | Mycapssa |
| Elutia, INC. | $33.50 | 2019 | |
| Lilly USA, LLC | $28.92 | 2023 | Jardiance |
| Cardiva Medical, INC. | $28.72 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Mannkind Corporation | $24.13 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.43 | 2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $20.29 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $19.77 | 2022 | |
| Zealand Pharma US, INC. | $18.09 | 2020 | |
| Novo Nordisk INC | $17.99 | 2024 | Ozempic |
| Lexicon Pharmaceuticals, INC. | $16.67 | 2023 | Inpefa |
| Xeris Pharmaceuticals, INC. | $16.41 | 2024 | Gvoke Hypopen |
| Tandem Diabetes Care, INC. | $12.79 | 2021 | |
| Medtronic Minimed, INC. | $11.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.